A multi-center study to evaluate the impact of germline BRCA1 and BRCA2 mutations on ovarian cancer survival

A multi-center study to evaluate the impact of germline BRCA1 and BRCA2 mutations on ovarian cancer survival

Bibliographic Details
Main Authors:	Bolton KL, Chenevix-Trench G, Goh C, Sadetzki S, Ramus SJ, Gayther SA, Chanock SJ, Antoniou AC, Pharoah PDP
Format:	Article
Language:	English
Published:	BMC 2012-04-01
Series:	Hereditary Cancer in Clinical Practice
Online Access:	http://www.hccpjournal.com/content/10/S2/A27

Similar Items

Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer
by: Tingyan Shi, et al.
Published: (2018-07-01)

Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru
by: Yomali Ferreyra, et al.
Published: (2023-08-01)

Prostate Cancer: Germline Mutations in BRCA1 and BRCA2
by: Pankaja Umarane, et al.
Published: (2023-03-01)

Frequency of germline mutations in BRCA1 and BRCA2 in ovarian cancer patients and their effect on treatment outcome
by: Ashour M, et al.
Published: (2019-07-01)

An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers
by: Ewa Przybytkowski, et al.
Published: (2020-03-01)

BRCA germline mutation test for all woman with ovarian cancer?
by: A. V. Paradiso, et al.
Published: (2019-06-01)

Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer
by: Yong Jae Lee, et al.
Published: (2020-03-01)

Searching for BRCA3 by exome sequencing
by: Makunin I, et al.
Published: (2012-04-01)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
by: Kara N. Maxwell, et al.
Published: (2017-08-01)

Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients
by: Yunuo Zhang, et al.
Published: (2022-08-01)

Germline mutations in BRCA1 and BRCA2 among Brazilian women with ovarian cancer treated in the Public Health System
by: Caroline de Oliveira Ferreira, et al.
Published: (2024-04-01)

Evaluation of germline BRCA1 and BRCA2 mutations in a multi-ethnic Asian cohort of ovarian cancer patients
by: Hasmad, HN, et al.
Published: (2015)

Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer
by: Arianna Nicolussi, et al.
Published: (2019-04-01)

Reliability of Tumor Testing Compared to Germline Testing for Detecting BRCA1 and BRCA2 Mutations in Patients with Epithelial Ovarian Cancer
by: Christine Bekos, et al.
Published: (2021-06-01)

The Features of BRCA1 and BRCA2 Germline Mutations in Hakka Ovarian Cancer Patients: BRCA1 C.536 A>T Maybe a Founder Mutation in This Population
by: Luo Y, et al.
Published: (2022-03-01)

BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients
by: Yinmei Zhang, et al.
Published: (2024-01-01)

Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland
by: Elżbieta Złowocka-Perłowska, et al.
Published: (2022-04-01)

Novel and recurrent BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer: a series from the south of Tunisia
by: Dorra Ben Ayed-Guerfali, et al.
Published: (2021-03-01)

The occurrence of germline <it>BRCA1 </it>and <it>BRCA2 </it>sequence alterations in Slovenian population
by: Hočevar Marko, et al.
Published: (2011-01-01)

Psychosexual Morbidity in Women With Ovarian Cancer: Evaluation by Germline BRCA Gene Mutational Status
by: Chloe A. Logue, MBChB, MRes, et al.
Published: (2022-02-01)

Patterns and duration of primary and recurrent treatment in ovarian cancer patients with germline BRCA mutations
by: Soledad Jorge, et al.
Published: (2019-08-01)

BRCA1, BRCA2, and TP53 germline and somatic variants and clinicopathological characteristics of Brazilian patients with epithelial ovarian cancer
by: Caroline Stahnke Richau, et al.
Published: (2024-02-01)

Tumor Testing for Somatic and Germline BRCA1/BRCA2 Variants in Ovarian Cancer Patients in the Context of Strong Founder Effects
by: Ana Peixoto, et al.
Published: (2020-07-01)

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population
by: J. Maksimenko, et al.
Published: (2018-06-01)

BRCA Germline Mutations in Prostate Cancer: The Future Is Tailored
by: Felice Crocetto, et al.
Published: (2021-05-01)

Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2 Germline Mutation?
by: Emiroglu S, et al.
Published: (2023-02-01)

Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan
by: Hikmat Abdel-Razeq, et al.
Published: (2018-02-01)

Rare Germline Genetic Variants and the Risks of Epithelial Ovarian Cancer
by: Marina Pavanello, et al.
Published: (2020-10-01)

Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome
by: Daniele Fanale, et al.
Published: (2021-06-01)

Cancer Spectrum, Family History of Cancer and Overall Survival in Men with Germline <i>BRCA1</i> or <i>BRCA2</i> Mutations
by: Florian Reichl, et al.
Published: (2021-09-01)

Germline and Somatic BRCA1/2 Mutations in 172 Chinese Women With Epithelial Ovarian Cancer
by: Yan You, et al.
Published: (2020-03-01)

The characteristics of determination of BRCA1 and BRCA2 mutations in serous ovarian cancer
by: I A Demidova
Published: (2017-01-01)

A role of <it>BRCA1 </it>and <it>BRCA2 </it>germline mutations in breast cancer susceptibility within Sardinian population
by: Lovicu Mario, et al.
Published: (2009-07-01)

Prevalence and predictors of germline BRCA1 and BRCA2 mutations among young patients with breast cancer in Jordan
by: Hikmat Abdel-Razeq, et al.
Published: (2021-07-01)

Erratum: Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome
by: Frontiers Production Office
Published: (2022-05-01)

Recurrent Germline BRCA2 Gene Mutation in Lithuanian Family
by: Ieva Sadzevičienė, et al.
Published: (2020-03-01)

Overview on population screening for carriers with germline BRCA mutation in China
by: Huijun Lei, et al.
Published: (2022-11-01)

Age-specific breast and ovarian cancer risks associated with germline BRCA1 or BRCA2 pathogenic variants – an Asian study of 572 familiesResearch in context
by: Weang-Kee Ho, et al.
Published: (2024-03-01)

Survival Outcomes and Efficacy of Platinum in Early Breast Cancer Patients with Germline BRCA1 or BRCA2 Mutation: A Multicenter Retrospective Cohort Study
by: Chen X, et al.
Published: (2023-09-01)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2.
by: Melissa S Cline, et al.
Published: (2018-12-01)